Astria Therapeutics
ATXS
ATXS
80 hedge funds and large institutions have $286M invested in Astria Therapeutics in 2023 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
67% more capital invested
Capital invested by funds: $171M → $286M (+$114M)
20.62% more ownership
Funds ownership: 81.96% → 102.58% (+21%)
18% more funds holding
Funds holding: 68 → 80 (+12)
Holders
80
Holding in Top 10
2
Calls
$345K
Puts
$120K
Top Buyers
| 1 | +$24.8M | |
| 2 | +$17.2M | |
| 3 | +$13.9M | |
| 4 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$12.7M |
| 5 |
AC
Armistice Capital
New York
|
+$12.1M |
Top Sellers
| 1 | -$7.9M | |
| 2 | -$7.74M | |
| 3 | -$4.74M | |
| 4 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
-$1.75M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$1.15M |